Sleep apnoea in heart failure

European Respiratory Journal

Volumn 29, Issue 6, 2007, Pages 1201-1205

  Schulz, Richard ^a   Blau, A ^b   Borgel J ^c   Duchna, H W ^c   Fietze, I ^b   Koper, I ^d   Prenzel, R ^e   Schadlich S ^f   Schmitt, J ^g   Tasci, S ^h   Andreas, S ⁱ  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

^d SANA KLINIKUM OFFENBACH   (Germany)

^e Plus Hospital   (Germany)

^f Hospital Martha Maria Halle Dölau   (Germany)

^g St Hedwig Klinik GmbH   (Germany)

^h UNIVERSITY HOSPITAL BONN   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cheyne stokes respiration; Congestive heart failure; Obstructive sleep apnoea

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; FEMALE; GERMANY; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICHANNEL RECORDER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SLEEP APNEA SYNDROME; SYMPTOM;

AGED; CHEYNE-STOKES RESPIRATION; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; POLYSOMNOGRAPHY; PRESSURE; RESPIRATION; SLEEP; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE;

EID: 34250194636     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00037106     Document Type: Article

References (22)

1. Study group on Heart Failure Awareness and Perecption in Europe. www.heartfailure-europe.com. Date last accessed: January 2007.
2. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402.
3. javaheri S, Parker TJ, Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122: 487-492.
4. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences and presentations. Circulation 1998; 97: 2154-2159.
5. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-1106.
6. 2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 1998; 128: 204-207.
7. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
8. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28: 596-602.
9. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996; 153: 272-276.
10. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99: 1435-1440.
11. Carmona-Bernal C, Quintana-Gallego E, Villa-Gil M, Sanchez-Armengol A, Martinez-Martinez A, Capote F. Brain natriuretic peptide in patients with congestive heart failure and central sleep apnea. Chest 2005; 127: 1667-1673.
12. van de Borne P, Oren R, Abouassaly C, Anderson E, Somers VK. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1998; 81: 432-436.
13. Leung RS, Diep TM, Bowman ME, Lorenzi-Filho G, Bradley TD. Provocation of ventricular ectopy by Cheyne-Stokes respiration in patients with heart failure. Sleep 2004; 27: 1337-1343.
14. Norman RG, Ahmed MM, Walsleben JA, Rapoport DM. Detection of respiratory events during NPSG: nasal cannula/pressure sensor versus thermistor. Sleep 1997; 20: 1175-1184.
15. Tremel F, Pepin JL, Veale D, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999; 20: 1201-1209.
16. Mared L, Cline C, Erhardt L, Berg S, Midgren B. Cheyne-Stokes respiration in patients hospitalised for heart failure. Respir Res 2004; 5: 14.
17. Campbell SC, Lauver GL, Cobb RB Jr. Central ventilatory depression by oral propranolol. Clin Pharmacol Ther 1981; 30: 758-764.
18. Köhnlein T, Welte T. Does beta-blocker treatment influence central sleep apnoea? Respir Med 2007; 101: 850-853.
19. Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007; 131: 130-135.
20. Gabor JY, Newman DA, Barnard-Roberts V, et al. Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J 2005; 26: 95-100.
21. Quintana-Gallego E, Villa-Gil M, Carmona-Bernal C, et al. Home respiratory polygraphy for diagnosis of sleep-disordered breathing in heart failure. Eur Respir J 2004; 24: 443-448.
22. Drechsler K, Dietz R, Klein H, et al. Euro heart failure survey. Medical treatment not in line with current guidelines. Z Kardiol 2005; 94: 510-515.